(1)
Petersen, P. C.; Petersen, L. N.; Vogelius, I.; Bjerregaard, J. K.; Baeksgaard, L. A Randomized Phase 2 Trial of First-Line Docetaxel, Carboplatin, Capecitabine (CTX) and Epirubicin, Oxaliplatin, Capecitabine (EOX) in Advanced Esophagogastric Adenocarcinoma. AO 2021, 60, 948-953.